These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1372049)

  • 1. alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs.
    Willins DL; Wallace LJ; Miller DD; Uretsky NJ
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1145-51. PubMed ID: 1372049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA, kainic acid, and N-methyl-D-aspartic acid stimulate locomotor activity after injection into the substantia innominata/lateral preoptic area.
    Shreve PE; Uretsky NJ
    Pharmacol Biochem Behav; 1989 Sep; 34(1):101-6. PubMed ID: 2696980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of quisqualic acid receptors in the hypermotility response produced by the injection of AMPA into the nucleus accumbens.
    Shreve PE; Uretsky NJ
    Pharmacol Biochem Behav; 1988 Jun; 30(2):379-84. PubMed ID: 2902646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA/kainic acid glutamate receptor antagonism in the zona incerta dorsal to the subthalamic nucleus inhibits amphetamine-induced stereotypy bur not locomotor activity.
    Supko DE; Uretsky NJ; Wallace LJ
    Brain Res; 1992 Mar; 576(1):89-96. PubMed ID: 1325238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.
    Boldry RC; Kelland MD; Engber TM; Chase TN
    Brain Res; 1993 Jan; 600(2):331-4. PubMed ID: 7679606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GABAergic transmission in the subpallidal region on the hypermotility response to the administration of excitatory amino acids and picrotoxin into the nucleus accumbens.
    Shreve PE; Uretsky NJ
    Neuropharmacology; 1988 Dec; 27(12):1271-7. PubMed ID: 2907617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
    Kaddis FG; Wallace LJ; Uretsky NJ
    Pharmacol Biochem Behav; 1993 Nov; 46(3):703-8. PubMed ID: 7506423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA and glutamate interact in the substantia innominata/lateral preoptic area to modulate locomotor activity.
    Shreve PE; Uretsky NJ
    Pharmacol Biochem Behav; 1991 Feb; 38(2):385-8. PubMed ID: 1676174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of AMPA/kainic acid glutamate receptors in the zona incerta stimulates locomotor activity.
    Supko DE; Uretsky NJ; Wallace LJ
    Brain Res; 1991 Nov; 564(1):159-63. PubMed ID: 1663813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801.
    Willins DL; Narayanan S; Wallace LJ; Uretsky NJ
    Pharmacol Biochem Behav; 1993 Dec; 46(4):881-7. PubMed ID: 8309969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA.
    Boldry RC; Willins DL; Wallace LJ; Uretsky NJ
    Brain Res; 1991 Sep; 559(1):100-8. PubMed ID: 1685936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference.
    Layer RT; Uretsky NJ; Wallace LJ
    Brain Res; 1993 Jul; 617(2):267-73. PubMed ID: 8402155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
    Layer RT; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):21-6. PubMed ID: 1685784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions.
    Boldry RC; Layer RT; Wallace LJ; Uretsky NJ
    Neurosci Lett; 1992 Apr; 138(2):265-9. PubMed ID: 1376874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of excitatory amino acid receptors may mediate the folate-induced stimulation of locomotor activity after bilateral injection into the rat nucleus accumbens.
    Stephens RL; Lee T; Boldry R; Uretsky NJ
    J Pharmacol Exp Ther; 1986 Dec; 239(3):627-33. PubMed ID: 3025414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of locomotor and conditioned place preference responses following manipulation of GABA-A and AMPA receptors in ventral pallidum.
    Gong W; Justice JB; Neill D
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):839-52. PubMed ID: 9278955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPA glutamate receptor activation in the posterior zona incerta inhibits amphetamine- and apomorphine-induced stereotypy.
    Supko DE; Wallace LJ
    Brain Res; 1992 Jul; 584(1-2):213-8. PubMed ID: 1381265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment.
    Massicotte G; Baudry M
    Neurosci Lett; 1990 Oct; 118(2):245-8. PubMed ID: 2177177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous AMPA/kainate receptor blockade and dopamine D(2/3) receptor stimulation in the nucleus accumbens decreases brain stimulation reward in rats.
    Choi KH; Clements RL; Greenshaw AJ
    Behav Brain Res; 2005 Mar; 158(1):79-88. PubMed ID: 15680196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E; Cox JA; Seeburg PH; Verdoorn TA
    Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.